Valvular & structural heart disease

Predictors of outcome in patients with moderate mixed aortic valve disease

HeartPublished Retrospective cohort study

Authors' conclusion

Patients with truly moderate MAVD have a high incidence of death and heart failure hospitalisation (43% at 3.5 (2.5-4.7) years). Within this group, a high-risk group characterised by disproportionately low aortic Vmax (≤2.8 m/s) and adverse remodelling (LVEF ≤50%) have the worst outcomes.

Study context

Population
Patients with moderate mixed aortic stenosis and regurgitation (aortic valve area (AVA) 1.0–1.5 cm² and vena contracta (VC) 0.3–0.6 cm), diagnosed 2015–2019
Participants
207 patients
Outcome
Composite of:
  • Death
  • HF hospitalisation
Follow-up
3.5 (2.5-4.7) years
Methodological detailsmulticentre registry, consecutive patients
  • Multicentre registry
  • Consecutive patients

Main finding

As reported in the abstract

Death or HF hospitalisation; independent predictors (multivariable) · 3.5 (2.5-4.7) years
Composite outcome incidence
89 patients (43%)
Peak aortic jet velocity (Vmax), HR
0.63 (95% CI 0.43 to 0.93; p=0.021)
Age, HR
1.05 (95% CI 1.03 to 1.08; p<0.001)
Creatinine, HR
1.002 (95% CI 1.001 to 1.003; p=0.005)
Previous cerebrovascular event (85% vs 42%), HR
3.04 (95% CI 1.54 to 5.99; p=0.001)
Left ventricular ejection fraction (LVEF), HR
0.97 (95% CI 0.95 to 0.99; p=0.007)

Observational data: associations, not effects.

Further findings

OutcomeVmax ≤2.8 m/s and LVEF ≤50%Rest of populationHR (95% CI)P value
Death or HF hospitalisation, Vmax ≤2.8 m/s and LVEF ≤50% (n=27)vs rest of population72%41%3.87 (2.20–6.80)P < 0.001

Univariable associations with primary outcome

Older age, previous MI, previous cerebrovascular event, AF, NYHA >2, worse renal function, tricuspid regurgitation ≥2 and mitral regurgitation ≥2 associated with primary outcome
Markers of biventricular systolic function, cardiac remodelling and transaortic valve haemodynamics inversely associated

Original publication

Predictors of outcome in patients with moderate mixed aortic valve disease. Heart. Published 26 December 2023. doi:10.1136/heartjnl-2023-323321

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.